We use cookies on this site to enhance your user experience
By continuing the navigation on this site you are giving your consent for us to set cookies.
More Info
Medacta announces today that more than 500,000 patientsworldwide have undergone hip replacement surgery with the innovative AMIS® (Anterior Minimally Invasive Surgery) technique, which is uniquely complemented by a tailored education program and a comprehensive package of implants, instruments and digital solutions, to address the specific needs of patients, surgeons and care facilities.
Medacta announced today the launch of its unique NextAR™ Shoulder, the first CE marked and FDA cleared augmented reality surgical application with intraoperative guidance for total shoulder replacement, following the responsible introduction in accordance with the M.O.R.E. Excellence Clinical Program's plan of action.
